Skip to main content Back to Top
Advertisement

2/5/2020

Hydralazine injection

Products Affected - Description

    • Hydralazine injection, X-Gen, 20 mg/mL, 1 mL vial, 25 count, NDC 39822-0500-04

Reason for the Shortage

    • Akorn has hydralazine available.
    • American Regent is not currently marketing hydralazine injection.
    • Fresenius Kabi has hydralazine available.
    • X-Gen did not provide a reason for the shortage.

Available Products

    • Hydralazine injection, Akorn, 20 mg/mL, 1 mL vial, 25 count, NDC 17478-0934-15
    • Hydralazine injection, Fresenius Kabi, 20 mg/mL, 1 mL vial, 25 count, NDC 63323-0614-01

Estimated Resupply Dates

    • X-Gen has hydralazine 20 mg/mL 1 mL vials on back order and the company cannot estimate a release date.

Updated

Updated February 5, 2020 by Anthony Trovato, PharmD, BCPS. Created June 4, 2018 by Anthony Trovato, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins